EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 105 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $68,264 | -36.5% | 12,190 | -40.6% | 0.00% | -66.7% |
| Q1 2024 | $107,541 | -47.1% | 20,523 | -47.2% | 0.00% | -57.1% |
| Q4 2023 | $203,447 | -9.8% | 38,900 | +172.0% | 0.01% | -22.2% |
| Q3 2023 | $225,511 | -24.7% | 14,300 | -7.1% | 0.01% | -18.2% |
| Q2 2023 | $299,376 | -58.5% | 15,400 | -39.5% | 0.01% | -63.3% |
| Q1 2023 | $722,045 | +240.1% | 25,451 | +250.4% | 0.03% | +172.7% |
| Q4 2022 | $212,327 | -11.2% | 7,264 | +54.6% | 0.01% | -26.7% |
| Q4 2021 | $239,000 | -15.2% | 4,700 | -28.8% | 0.02% | -44.4% |
| Q2 2021 | $282,000 | +22.6% | 6,600 | +20.0% | 0.03% | +28.6% |
| Q1 2021 | $230,000 | – | 5,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
| Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
| GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
| SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
| BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
| Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
| Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
| Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
| Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
| SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |